In memoriam: Jeffrey Cameron
Jeffrey Cameron, an associate professor of biochemistry at the University of Colorado Boulder, passed away on September 25 at the age of 43 in Colorado. He made seminal contributions to understanding microbe cellular processes.
Born on February 16, 1981, in La Grange, Illinois, Cameron studied plant science at Montana State University and Washington University, where he obtained his Ph.D. and completed his postdoctoral training.
In 2015, he opened his lab at CU Boulder, which focused on understanding the physiology, cell biology and biochemistry of the photosynthetic microbe, cyanobacteria. His research on cellular signaling and metabolic regulation in cyanobacteria aimed to harness their carbon-fixing mechanisms to combat climate change, leading to innovations like bacteria-grown biomaterials that reduce emissions from traditional cement production. In 2016, Cameron cofounded the biotech company Prometheus Materials, which uses microalgae to create zero-carbon bio-cement and bio-concrete.
Cameron was also a mentor and educator. Many of his students and colleagues remember him for his brilliance as well as his kindness. He was deeply committed to fostering a collaborative research environment and was known for his generosity in sharing knowledge.
Outside of the lab, Cameron enjoyed cooking, hiking and mushroom hunting.
He is survived by his wife, Jennifer Michelle Cameron, and four children, Noelle Rose, Jasper Carlyle, Evette Blue and Margot Love. He is also survived by his parents, three siblings and three grandparents.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles
In memoriam: Michael J. Chamberlin
He discovered RNA polymerase and was an ASBMB member for nearly 60 years.
Building the blueprint to block HIV
Wesley Sundquist will present his work on the HIV capsid and revolutionary drug, Lenacapavir, at the ASBMB Annual Meeting, March 7–10, in Maryland.
In memoriam: Alan G. Goodridge
He made pioneering discoveries on lipid metabolism and was an ASBMB member since 1971.
Alrubaye wins research and teaching awards
He was honored at the NACTA 2025 conference for the Educator Award and at the U of A State and National Awards reception for the Faculty Gold Medal.
Designing life’s building blocks with AI
Tanja Kortemme, a professor at the University of California, San Francisco, will discuss her research using computational biology to engineer proteins at the 2026 ASBMB Annual Meeting.
Jordahl named Gilliam Fellow
He will receive three years of funding to support his thesis research.